ABCG1 and neoplasm: We examined tumor tissues from subcutaneous xenografts by immunohistochemistry and also observed a decreased proportion of ABCG1 in IP6 treatment group (10.67 ± 6.43 vs. 26.12 ± 5.29, p = 0.0332; Figure 3C).